Bodyport secures FDA 510(k) clearance for the Bodyport Cardiac Scale. LEARN MORE

Research & Press

At Bodyport, we take heart health seriously and apply the appropriate technological rigor and clinical expertise to ensure our products and services meet industry standards. Real-world evidence is important to us and our partners. And we know it matters to you—see for yourself.

August 09, 2022

Bodyport Receives FDA Clearance for the Bodyport Cardiac Scale

Read more

August 02, 2022

Assessing Heart Function and Fluid Status with Cardiac Scales: Interview with John Lipman, CEO, and Corey Centen, Founder, Bodyport

Read more

June 23, 2022

Bodyport Announces Appointment of Jim Pursley to Board of Directors

Read more

June 23, 2022

Wearables are collecting a flood of data. An ambitious new study of pregnancy aims to prove that’s valuable for health

Read more

June 15, 2022

Bodyport Appoints John Lipman as Chief Executive Officer

Read more

April 08, 2022

Feasibility of a Cardiac Scale in Measuring Blood Pressure, Journal of Cardiovascular Translational Research, JCTR

Read more

March 08, 2022

Outpatient heart failure monitoring with a novel cardiac scale: tracking volume status, Journal of American College of Cardiology, JACC

Read more

December 07, 2021

Noninvasive Scale Measurement of Stroke Volume and Cardiac Output Compared With the Direct Fick Method: A Feasibility Study, Journal of American Heart Failure, JAHA

Read more

April 13, 2021

Bodyport Appoints Amit Rushi as Chief Commercial Officer and Phyllis Whiteley, Ph.D. as Chair of the Board of Directors

Read more

August 11, 2020

Bodyport raises $11.2 million in Series A funding to launch virtual cardiac clinic

Read more

Bodyport Inc
970 Folsom St
San Francisco CA 

Subscribe to receive the latest news from Bodyport

This field is for validation purposes and should be left unchanged.

Bodyport is a Member of the American Heart Association’s Innovators’ Network

Copyright © 2022 Bodyport Inc. All Rights Reserved.